You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
Nonsynonymous, coding sequence single-nucleotide polymorphisms in β2-adrenergic receptors were first recognized almost 20 years ago, but a full understanding of their impact on signal transduction—especially on receptor abundance in native cells and their clinical importance—remains unclear. New evidence has revealed a feature of the Arg16Gly variant of β2-adrenergic receptors that has not been previously noted: a difference in the rate of response upon repeated stimulation of the receptors, such that the Arg16 variant shows slower activation and the Gly16 variant faster activation of cyclic adenosine monophosphate (cAMP) formation—a feature that the authors term “receptor memory.” This is an intriguing idea but will require confirmation and demonstration of its functional importance in vivo and its possible contribution to clinical responses, especially in terms of the administration of β2-adrenergic agonists.
